SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : COMPUTERIZED THERMAL IMAGING (COII)- research only
CIO 6.970+0.1%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (219)6/23/2000 12:57:00 AM
From: chirodoc  Read Replies (1) of 256
 
CTI Announces First Sale of its New Breast Cancer Imaging System
Unique Non-Invasive Advancement Aids Physicians in Diagnosis of Breast Cancer
LAYTON, Utah--(BUSINESS WIRE)--June 19, 2000--Computerized Thermal Imaging, Inc. (CTI) (OTC symbol: COII - news) announced today the sale of 10 CTI breast cancer imaging systems to a Latin American consortium based in Mexico City for $5 million.

This consortium, Computerized Thermal Imaging International, and CTI had previously announced an agreement to deploy 100 CTI breast cancer imaging units in Latin America. This initial purchase order was accompanied by a down payment of $1.75 million, with the balance due upon delivery of the systems.

``This is a very significant event in our corporate history,'' stated David Packer, President and COO. ``It represents the first sale of our revolutionary breast cancer imaging system and our first significant revenues. This achievement is the result of our unwavering commitment to bring this product to market successfully. Our recent acquisition of Bales Scientific will greatly enhance both production and support. We will now begin production as well as total implementation of the domestic and international product support infrastructure.''

CTI is seeking FDA approval for use of its Computerized Thermal Imaging System in the United States as an adjunctive diagnostic test to mammography and clinical examination for the detection of breast cancer. The test is simple, painless, and involves no radiation, breast compression, electrodes, electrical current, or skin contact. CTI also recently announced evaluation of their technology for new occupational medicine applications.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext